Kerala Ayurveda Ltd

Kerala Ayurveda Ltd., the speciality ayurvedic medicines manufacturer, reported a consolidated net loss of ₹7.76 crores for Q4 FY26, marking a deterioration of 74.38% quarter-on-quarter and a staggering 50.06% decline year-on-year. The company, with a market capitalisation of ₹272.00 crores, continues to grapple with severe operational challenges that have eroded profitability despite modest revenue growth. Shares have plummeted 48.15% over the past year, trading at ₹211.00 as investors flee amidst mounting concerns about the company's financial viability.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 May 2026, providing investors with the latest insights into its performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Despite a broader market recovery, Kerala Ayurveda Ltd has plunged to a fresh 52-week low of Rs 150 on 30 Mar 2026, extending its recent losing streak and underperforming its sector by 2.79% today.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Kerala Ayurveda Ltd’s shares touched a fresh 52-week low of Rs.161.05 today, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. Despite a volatile trading session, the stock remains below all key moving averages, reflecting persistent downward momentum.

Kerala Ayurveda Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.162 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and market performance.

Kerala Ayurveda Ltd’s shares fell sharply to a new 52-week low of Rs.163.7 on 13 Mar 2026, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its peers and broader market indices, reflecting persistent financial and market challenges.

Kerala Ayurveda Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.180 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial and technical performance.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 March 2026, providing investors with the latest insights into the stock’s performance and fundamentals.

Kerala Ayurveda Ltd’s shares have declined to a fresh 52-week low of Rs.194, marking a significant downturn for the Pharmaceuticals & Biotechnology company. The stock has been under pressure for several sessions, reflecting ongoing concerns about its financial health and market performance.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Kerala Ayurveda Ltd’s shares declined to a fresh 52-week low of Rs.196.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector.

Kerala Ayurveda Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.210 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued performance metrics.